BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12133763)

  • 1. Alopecia associated with atorvastatin.
    Segal AS
    Am J Med; 2002 Aug; 113(2):171. PubMed ID: 12133763
    [No Abstract]   [Full Text] [Related]  

  • 2. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves.
    Jiménez-Alonso J; Osorio JM; Gutiérrez-Cabello F; López de la Osa A; León L; Mediavilla García JD
    Arch Intern Med; 1999 Aug 9-23; 159(15):1811-2. PubMed ID: 10448788
    [No Abstract]   [Full Text] [Related]  

  • 3. Rhabdomyolysis in a patient receiving atorvastatin and fluconazole.
    Kahri J; Valkonen M; Bäcklund T; Vuoristo M; Kivistö KT
    Eur J Clin Pharmacol; 2005 Feb; 60(12):905-7. PubMed ID: 15625612
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible atorvastatin-associated external ophthalmoplegia, anti-acetylcholine receptor antibodies, and ataxia.
    Negevesky GJ; Kolsky MP; Laureno R; Yau TH
    Arch Ophthalmol; 2000 Mar; 118(3):427-8. PubMed ID: 10721974
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atorvastatin . A new generation of hypolipemic agents?].
    Azanza JR; Sádaba B; Quetglas EG
    Rev Med Univ Navarra; 1998; 42(1):51-5. PubMed ID: 10420957
    [No Abstract]   [Full Text] [Related]  

  • 6. Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.
    Chong PH; Seeger JD
    Pharmacotherapy; 1997; 17(6):1157-77. PubMed ID: 9399600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of statin therapy in patients with mitochondrial diseases.
    Hannah-Shmouni F; Al-Sarraf A; Frohlich J; Mezei MM; Sirrs S; Mattman A
    J Clin Lipidol; 2013; 7(2):182. PubMed ID: 23415441
    [No Abstract]   [Full Text] [Related]  

  • 8. Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation.
    Shechter M
    Circulation; 2003 Jun; 107(22):e210; author reply e210. PubMed ID: 12796420
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute hepatic injury with atorvastatin: an unusual occurrence.
    Vishwakarma P; Nehra R; Kumar A
    Indian J Pharmacol; 2014; 46(3):343-4. PubMed ID: 24987187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin-associated myotoxicity in an incarcerated Indigenous youth - the perfect storm.
    Haysom L; Samaras K; Stapylton C; Wines J
    Med J Aust; 2015 Apr; 202(7):381-2. PubMed ID: 25877122
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of monthly atorvastatin treatment on hemostasis.
    Okopien B; Krysiak R; Herman ZS
    Int J Clin Pharmacol Ther; 2004 Nov; 42(11):589-93. PubMed ID: 15598024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort.
    Ann Intern Med; 2014 Mar; 160(5):I-34. PubMed ID: 24737270
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of HMG-CoA reductase inhibitors: focus on atorvastatin.
    Bernini F; Poli A; Paoletti R
    Cardiovasc Drugs Ther; 2001; 15(3):211-8. PubMed ID: 11713888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin is an effective and well-tolerated treatment alternative for patients not achieving target lipid goals with simvastatin.
    Eugenio KR; Alexis G; Kelliher AF; Henault RG; Vieira JA
    J Am Pharm Assoc (2003); 2003; 43(5):637-9. PubMed ID: 14626757
    [No Abstract]   [Full Text] [Related]  

  • 15. Atorvastatin for stroke prevention.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287
    [No Abstract]   [Full Text] [Related]  

  • 16. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.
    Malhotra HS; Goa KL
    Drugs; 2001; 61(12):1835-81. PubMed ID: 11693468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia.
    Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
    Acta Cardiol; 2006 Jun; 61(3):263-9. PubMed ID: 16869445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of tachyphylaxis on statin treatment.
    Miserez AR; Keller U; Mirsaidi R
    Am J Cardiol; 2001 Oct; 88(8):936-7. PubMed ID: 11676971
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful reintroduction of statin therapy after myositis: was there another cause?
    Rando LP; Cording SA; Newnham HH
    Med J Aust; 2004 May; 180(9):472-3. PubMed ID: 15115429
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia.
    Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R
    Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.